Feng, H.; He, L.; Umar, T.; Wang, X.; Li, W.; Zhang, B.; Zhu, X.; Deng, G.; Qiu, C.
Synergistic Antitumor Effects of Ivermectin and Metformin in Canine Breast Cancer via PI3K/AKT/mTOR Pathway Inhibition. Curr. Issues Mol. Biol. 2025, 47, 403.
https://doi.org/10.3390/cimb47060403
AMA Style
Feng H, He L, Umar T, Wang X, Li W, Zhang B, Zhu X, Deng G, Qiu C.
Synergistic Antitumor Effects of Ivermectin and Metformin in Canine Breast Cancer via PI3K/AKT/mTOR Pathway Inhibition. Current Issues in Molecular Biology. 2025; 47(6):403.
https://doi.org/10.3390/cimb47060403
Chicago/Turabian Style
Feng, Huili, Lixin He, Talha Umar, Xiao Wang, Wenxuan Li, Bohan Zhang, Xinying Zhu, Ganzhen Deng, and Changwei Qiu.
2025. "Synergistic Antitumor Effects of Ivermectin and Metformin in Canine Breast Cancer via PI3K/AKT/mTOR Pathway Inhibition" Current Issues in Molecular Biology 47, no. 6: 403.
https://doi.org/10.3390/cimb47060403
APA Style
Feng, H., He, L., Umar, T., Wang, X., Li, W., Zhang, B., Zhu, X., Deng, G., & Qiu, C.
(2025). Synergistic Antitumor Effects of Ivermectin and Metformin in Canine Breast Cancer via PI3K/AKT/mTOR Pathway Inhibition. Current Issues in Molecular Biology, 47(6), 403.
https://doi.org/10.3390/cimb47060403
